307 related articles for article (PubMed ID: 7468137)
1. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine.
Dercksen SJ; Linssen GH
Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
Dercksen SJ; Linssen GH
Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
[TBL] [Abstract][Full Text] [Related]
3. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T
Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
[TBL] [Abstract][Full Text] [Related]
4. [A computerized method for the administration of heparin and protamine during open-heart surgery].
Isshiki A; Sakaguchi Y; Kubota K; Ikeda T
Masui; 1984 Dec; 33(12):1323-8. PubMed ID: 6530734
[No Abstract] [Full Text] [Related]
5. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery.
Babka R; Colby C; El-Etr A; Pifarré R
J Thorac Cardiovasc Surg; 1977 May; 73(5):780-2. PubMed ID: 850438
[TBL] [Abstract][Full Text] [Related]
6. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
7. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
[TBL] [Abstract][Full Text] [Related]
8. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
[TBL] [Abstract][Full Text] [Related]
9. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
10. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
11. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
12. [The role of the activated coagulation time (ACT) in open heart surgery--comparison between children and adult patients].
Ohmi M; Tsuboi H; Furukawa S; Mohri H; Seo K
Kyobu Geka; 1984 Nov; 37(12):945-8. PubMed ID: 6521115
[No Abstract] [Full Text] [Related]
13. Activated clotting time for control of anticoagulation during surgery.
Lefemine AA; Lewis M
Am Surg; 1985 May; 51(5):274-8. PubMed ID: 3994170
[TBL] [Abstract][Full Text] [Related]
14. [Protamine dosage for heparin neutralization in open-heart surgery (author's transl)].
Shiao K
Fukuoka Igaku Zasshi; 1974 Nov; 65(11):878-88. PubMed ID: 4477114
[No Abstract] [Full Text] [Related]
15. A comparison between arterial- and venous-sampled activated clotting time measurements.
Zisman E; Rozenberg B; Katz Y; Ziser A
Isr J Med Sci; 1997 Dec; 33(12):786-8. PubMed ID: 9464347
[TBL] [Abstract][Full Text] [Related]
16. Activated clotting time monitoring of intraoperative heparinization: our experience and comparison of two techniques.
Mabry CD; Thompson BW; Read RC; Campbell GS
Surgery; 1981 Nov; 90(5):889-95. PubMed ID: 7302842
[TBL] [Abstract][Full Text] [Related]
17. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
Bull BS; Huse WM; Brauer FS; Korpman RA
J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
[TBL] [Abstract][Full Text] [Related]
19. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
Dauchot PJ; Berzina-Moettus L; Rabinovitch A; Ankeney JL
Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
[TBL] [Abstract][Full Text] [Related]
20. The relationship between heparin level and activated clotting time in the adult cardiac surgery population.
Fitzgerald DJ; Patel A; Body SC; Garvin S
Perfusion; 2009 Mar; 24(2):93-6. PubMed ID: 19654150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]